Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...
Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated platforms ...
Research and Development Expenses -- $9.6 million in the third quarter of 2025, down from $12.3 million in Q3 2024, due to ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that the first patient has been ...
The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, limit toxicity and elevate patient outcomes. Conventional oral ...
On a chilly April morning, Travis Gienger took his first gamble of the 2025 season. The world-champion giant-pumpkin grower ...
The Inflammatory Diseases Market, valued at USD 22.5 billion in 2025, is projected to reach USD 34.9 billion by 2035, ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
AZ Animals on MSN
Synthetic Biology May Be the Future of Wildlife Conservation
From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...
According to the HSRC report, Gross Domestic Expenditure on Research and Development (GERD) stood at R43.413 billion in ...
and G—that make up the genetic code. The prevailing belief was that by decoding these sequences, we could unlock how cells and organisms fundamentally work. Now, research from Northwestern Engineering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback